Definition: The word "respiratory syncytial virus vaccine" refers to a type of vaccine that can be administered in combination with other vaccines or medications to boost an infant's immune system against respiratory syncytial virus (RSV) infection. This type of vaccine is called a polysaccharide vaccine. In summary, this vaccine works by stimulating the infant's immune system to produce antibodies specifically for RSV, which will protect them from catching the disease. The key differences between this type of vaccine and other types are its focus on boosting an infant's immune system rather than simply providing protection against the infection itself.

Respiratory Syncytial Virus Vaccine

Definition: Respiratory syncytial virus (RSV) vaccine, adjuvanted: A type of vaccine that contains a live RSV virus in a weakened or genetically modified form to stimulate immune response. This method involves using human embryonic stem cells to produce large quantities of RSV virus and then adding it to the vaccine preparation, which makes it more potent and immunogenic than non-adjuvanted vaccines. The word 'Respiratory Syncytial Virus' (RSV) is a type of respiratory tract illness caused by the influenza virus. It is an important component of the seasonal flu vaccine that helps protect against serious complications such as pneumonia and severe acute respiratory syndrome (SARS). RSV is not a true virus, but rather the replication of an RNA virus, which can cause illness in humans or other animals. Adjuvanted vaccines are designed to be more potent than traditional non-adjuvanted vaccines by using adjuvants such as polyethylene glycol 400 (PEG 400), which helps increase the vaccine's potency and duration of action. Adjuvants work by attaching to the RSV virus, allowing it to be released into the body, where its protective properties can be recognized and activated. In summary: - RSV vaccine, adjuvanted: A type of vaccine that contains a live RSV virus in a weakened or genetically modified form to stimulate immune response. This method involves using human embryonic stem cells to produce large quantities of RSV virus and then adding it to the vaccine preparation, which makes it more potent and immunogenic than non-adjuvanted vaccines. - Adjuvant: A substance added to a vaccine to boost its potency and duration of action. In respiratory syncytial virus (RSV) vaccination, polyethylene glycol 400 is used for adjuvation to increase the vaccine's potency and prolong the immune response. - Influenza: An influenza virus that causes seasonal flu illnesses in humans. The word 'Respiratory Syncytial Virus' is a type of respiratory tract illness caused by the influenza virus. It is an important component of the seasonal flu vaccine that helps protect against serious complications such as pneumonia and severe acute respiratory syndrome (SARS).

Respiratory Syncytial Virus Vaccine, Adjuvanted